Can delaying surgery for retained pregnancy tissue save fertility?
NCT ID NCT07421895
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 600 women with retained products of conception (RPOC) to compare standard surgery versus a wait-and-see approach with medication. The goal is to see which method reduces scarring inside the uterus and better preserves the ability to get pregnant in the future. Researchers will track complications, need for additional surgery, and pregnancy rates within one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors choose the best treatment approach to preserve fertility in women with retained products of conception.
- What could go wrong
- This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETAINED PRODUCTS OF CONCEPTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Third Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, 410013, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.